☆ 4.8 Editorial Material

Commentary: Arguing for Adaptive Clinical Trials in Sepsis

FRONTIERS IN IMMUNOLOGY (2018)

Journal

FRONTIERS IN IMMUNOLOGY

Volume 9, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA

DOI: 10.3389/fimmu.2018.02507

Keywords

sepsis; adaptive clinical trials; Bayesian statistics; platform trials; response adaptive randomization

Categories

Immunology

Funding

Integrated Research and Treatment Center, Center for Sepsis Control and Care (CSCC), at the Jena University Hospital - German Ministry of Education and Research (BMBF) [01EO1502]
BMBF [01ZZ1803C]

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Article Medicine, Research & Experimental

Over-accrual in Bayesian adaptive trials with continuous futility stopping

Leandro Garcia Barrado, Tomasz Burzykowski

Summary: This study explores the frequentist operating characteristics of a Bayesian adaptive design that allows early stopping for futility. The results indicate that an increase in sample size leads to a decrease in power, which is attributed to the increasing cumulative probability of incorrectly stopping for futility. Various approaches, such as delaying the start of testing or setting stricter criteria, can be taken to address this issue.

CLINICAL TRIALS (2023)

Add to Collection

Article Computer Science, Interdisciplinary Applications

A Markov decision process for response-adaptive randomization in clinical trials

David Merrell, Thevaa Chandereng, Yeonhee Park

Summary: Response-adaptive randomization (RAR) in clinical trials can assign more subjects to better-performing treatments based on interim results. Blocked RAR is an alternate approach that groups patients together in blocks, providing robustness against time-trend bias. TRIALMDP is an algorithm for designing two-armed blocked RAR clinical trials, optimizing the size and number of blocks and their treatment allocations based on dynamic programming.

COMPUTATIONAL STATISTICS & DATA ANALYSIS (2023)

Add to Collection

Editorial Material Statistics & Probability

Comment: Is Response-Adaptive Randomization a Good Thing or Not in Clinical Trials? Why We Cannot Take Sides

Alessandra Giovagnoli

Summary: The paper by Robertson et al. aims to provide a comprehensive review of methodological and practical issues related to RAR in clinical trials. However, simulations conducted by different authors suggest that RAR may not be useful for statistical inference or patient care in the trial. The authors argue that the existing arguments against RAR are inconclusive, as they may be based on incomplete or incorrect inferential considerations and unconvincing simulation studies. They also highlight the common, yet often misunderstood, Bayesian perspective.

STATISTICAL SCIENCE (2023)

Add to Collection

Review Environmental Sciences

The Bayesian Design of Adaptive Clinical Trials

Alessandra Giovagnoli

Summary: This paper provides a brief overview of recent literature on Bayesian adaptive designs in clinical trials, emphasizing the importance of adaptive designs across various disciplines and their applications in clinical trials. It highlights the main conceptual tools and mentions several trial designs proposed in the literature, including some registered Bayesian adaptive trials.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2021)

Add to Collection

Article Anesthesiology

Bayesian predictive probabilities: a good way to monitor clinical trials

David Ferreira, Pierre-Olivier Ludes, Pierre Diemunsch, Eric Noll, Klaus D. Torp, Nicolas Meyer

Summary: By simulating a sequential analysis of a clinical trial, this paper illustrates the use of PredP in Bayesian methods. The results demonstrate that the equivalence determined by PredP is more accurate than that from frequentist analysis, allowing for early termination of the trial.

BRITISH JOURNAL OF ANAESTHESIA (2021)

Add to Collection

Article Health Care Sciences & Services

An overview of methodological considerations regarding adaptive stopping, arm dropping, and randomization in clinical trials

Anders Granholm, Benjamin Skov Kaas-Hansen, Theis Lange, Olav Lilleholt Schjorring, Lars W. Andersen, Anders Perner, Aksel Karl Georg Jensen, Morten Hylander Moller

Summary: This article provides thorough guidance on key methodological considerations for adaptive clinical trials. It discusses the pros and cons of adaptive stopping, adaptive arm dropping, and response-adaptive randomization, and provides guidance on using simulation to compare different adaptive trial designs. The article focuses on Bayesian multi-arm adaptive trials and covers various aspects such as intervention and possible common control, outcome selection, timing of adaptive analyses, decision rules for adaptive stopping and arm dropping, randomization strategies, performance metrics, simulations, and reporting.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2023)

Add to Collection

Article Health Care Sciences & Services

Personalized Risk-Based Screening Design for Comparative Two-Arm Group Sequential Clinical Trials

Yeonhee Park

Summary: This paper proposes a personalized risk-based screening design using Bayesian covariate-adjusted response-adaptive randomization for improved clinical trial outcomes under personalized medicine. The design effectively controls error rates and allocates more patients to better interventions.

JOURNAL OF PERSONALIZED MEDICINE (2022)

Add to Collection

Article Medicine, Research & Experimental

The design of a Bayesian adaptive clinical trial of tranexamic acid in severely injured children

John M. VanBuren, T. Charles Casper, Daniel K. Nishijima, Nathan Kuppermann, Roger J. Lewis, J. Michael Dean, Anna McGlothlin

Summary: This study proposes a Bayesian adaptive clinical trial to investigate TXA in children with brain and/or torso hemorrhagic trauma. The trial design allows for different injury populations to be compared within a single study framework, aiming to identify the optimal dose of TXA for various injury types in childhood to reduce death and disability. Extensive simulations have been conducted to evaluate the statistical design and ensure adequate power in each injury group.

TRIALS (2021)

Add to Collection

Article Medicine, Research & Experimental

Bayesian biomarker-driven outcome-adaptive randomization with an imperfect biomarker assay

Leandro Garcia Barrado, Tomasz Burzykowski

Summary: The study found that the use of an imperfect biomarker assay in a Bayesian biomarker-driven outcome-adaptive randomization design can significantly reduce power and increase the type-I error probability. The effects depend on the sensitivity, specificity of the assay, and the distribution of the biomarker in the patient population. With an imperfect biomarker assay, careful consideration is required for implementing a biomarker-driven outcome-adaptive randomization design.

CLINICAL TRIALS (2021)

Add to Collection

Article Medicine, Research & Experimental

Optimizing a Bayesian hierarchical adaptive platform trial design for stroke patients

Guangyi Gao, Byron J. Gajewski, Jo Wick, Jonathan Beall, Jeffrey L. Saver, Caitlyn Meinzer

Summary: Platform trials based on Bayesian designs can effectively investigate multiple treatment arms on heterogeneous patient populations. The proposed approach using hierarchical modeling, response-adaptive randomization, and adjustment for potential drift over time achieved high statistical power, good patient benefit, and robustness against population drift over time. This design strikes a balance between traditional RAR scheme and fixed allocation, making it a promising choice for dichotomous outcomes trials investigating multiple subgroups.

TRIALS (2022)

Add to Collection

Article Health Care Sciences & Services

A novel power prior approach for borrowing historical control data in clinical trials

Yaru Shi, Wen Li, Guanghan (Frank) Liu

Summary: There is growing interest in using historical control data to improve statistical power and reduce sample sizes in clinical trials. However, accounting for heterogeneity between historical and current trials can be challenging. This paper proposes a novel approach to selecting a power prior based on direct measures of distributional differences between historical and current control data. Simulations show that the proposed power prior improves study power and controls type I errors when the distribution of historical control data is similar to current control data.

STATISTICAL METHODS IN MEDICAL RESEARCH (2023)

Add to Collection

Article Computer Science, Interdisciplinary Applications

carat: An R Package for Covariate-Adaptive Randomization in Clinical Trials

Wei Ma, Xiaoqing Ye, Fuyi Tu, Feifang Hu

Summary: carat is an R package that allows for the implementation and evaluation of covariate-adaptive randomization methods. It provides a variety of randomization and testing procedures and includes comprehensive evaluation and comparison tools. carat also allows for power analysis to assist in the planning of covariate-adaptive clinical trials.

JOURNAL OF STATISTICAL SOFTWARE (2023)

Add to Collection

Article Mathematical & Computational Biology

Minimization in randomized clinical trials

Elisabeth Coart, Perrine Bamps, Emmanuel Quinaux, Genevieve Sturbois, Everardo D. Saad, Tomasz Burzykowski, Marc Buyse

Summary: In randomized trials, the comparability of treatment groups is ensured through random allocation of treatments. However, imbalances in prognostic factors among treatment groups may occur. To achieve balance, some procedures dynamically adapt allocation using covariate information. This tutorial compares the performance of minimization, a popular covariate-adaptive procedure, with two other commonly used procedures.

STATISTICS IN MEDICINE (2023)

Add to Collection

Article Neurosciences

Retrospective Bayesian Evidence of Null Effect in Two Decades of Alzheimer's Disease Clinical Trials

Tommaso Costa, Jordi Manuello, Franco Cauda, Donato Liloia

Summary: Despite intense research on Alzheimer's disease, no validated treatment to reverse symptoms or stop disease progression has been found. A recent systematic review focused on methodological factors as possible reasons for the failure of clinical trials, without detailed examination of statistical trends. This study aims to complete the picture using Bayesian analysis, testing whether the failure of these trials was due to insufficient statistical power or lack of a true effect. Strong Bayes' Factor supported the hypothesis of lack of a true effect.

JOURNAL OF ALZHEIMERS DISEASE (2023)

Add to Collection

Article Computer Science, Interdisciplinary Applications

Adaptive multidimensional integration: VEGAS enhanced

G. Peter Lepage

Summary: The VEGAS+ algorithm is more accurate than VEGAS in certain cases, especially for integrands with multiple peaks or structures aligned with diagonals of the integration volume. It can be combined with other integrators for better performance.

JOURNAL OF COMPUTATIONAL PHYSICS (2021)

Add to Collection

Article Infectious Diseases

Prospective surveillance study in a 1,400-bed university hospital: COVID-19 exposure at home was the main risk factor for SARS-CoV-2 point seroprevalence among hospital staff

Christina Bahrs, Aurelia Kimmig, Sebastian Weis, Juliane Ankert, Stefan Hagel, Jens Maschmann, Andreas Stallmach, Andrea Steiner, Michael Bauer, Wilhelm Behringer, Michael Baier, Miriam Kesselmeier, Cora Richert, Florian Zepf, Martin Walter, Andre Scherag, Michael Kiehntopf, Bettina Loffler, Mathias W. Pletz

Summary: A prospective cohort study among hospital staff in Jena University Hospital found a low risk of SARS-CoV-2 infection for healthcare workers, possibly due to high compliance in wearing personal protective equipment.

TRANSBOUNDARY AND EMERGING DISEASES (2022)

Add to Collection

Article Medicine, General & Internal

Mid-German Sepsis Cohort (MSC): a prospective observational study of sepsis survivorship

Carolin Fleischmann-Struzek, Miriam Kesselmeier, Dominique Ouart, Christiane S. Hartog, Michael Bauer, Sven Bercker, Michael Bucher, Andreas Meier-Hellmann, Sirak Petros, Torsten Schreiber, Philipp Simon, Lorenz Weidhase, Sebastian Born, Anke Braune, Hicham Chkirni, Cornelia Eichhorn, Sandra Fiedler, Christin Gampe, Christian Koenig, Stephanie Platzer, Heike Romeike, Kristin Toepfer, Konrad Reinhart, Andre Scherag

Summary: The Mid-German Sepsis Cohort (MSC) aims to investigate mid-term and long-term functional disabilities in sepsis survivors, as well as post-acute mortality, health-related quality of life, and healthcare utilization. To date, recruitment and baseline data collection have been completed, providing a unique resource for research on the long-term sequelae of sepsis survivors. The future plans include follow-up assessments at 3, 6, and 12 months after ICU discharge, with additional yearly follow-ups up to 5 years post-discharge. Several cooperation and satellite projects have been initiated to further explore the outcomes of sepsis survivors.

BMJ OPEN (2021)

Add to Collection

Letter Respiratory System

A longitudinal analysis of pneumococcal vaccine serotypes in pneumonia patients in Germany

Christina Bahrs, Miriam Kesselmeier, Martin Kolditz, Santiago Ewig, Gernot Rohde, Grit Barten-Neiner, Jan Rupp, Martin Witzenrath, Tobias Welte, Mathias W. Pletz

EUROPEAN RESPIRATORY JOURNAL (2022)

Add to Collection

Article Infectious Diseases

Comparison of fatigue, cognitive dysfunction and psychological disorders in post-COVID patients and patients after sepsis: is there a specific constellation?

Andreas Stallmach, Miriam Kesselmeier, Michael Bauer, Judith Gramlich, Kathrin Finke, Anne Fischer, Carolin Fleischmann-Struzek, Astrid Heutelbeck, Katrin Katzer, Stephanie Mutschke, Mathias W. Pletz, Stefanie Quickert, Konrad Reinhart, Zoe Stallmach, Martin Walter, Andre Scherag, Philipp A. Reuken

Summary: Sequelae of COVID-19 may include fatigue, depression, and cognitive dysfunction. Patients with post-COVID have a higher prevalence of fatigue and signs of depression compared to sepsis survivors, while cognitive dysfunction is associated with hospitalization.

INFECTION (2022)

Add to Collection

Meeting Abstract Oncology

Novel predictive biomarkers of response to immune checkpoint blockade with nivolumab ± ipilimumab in the TITAN-RCC phase 2 trial.

Marc-Oliver Grimm, Miriam Kesselmeier, Katharina Leucht, Ulrike Schumacher, Antje Tunger, Nadja Rober, Karsten Conrad, Ulrich Sommer, Gustavo Bruno Baretton, Andre Scherag, Laurence Albiges, Emilio Esteban, Philippe Barthelemy, Manuela Schmidinger, Jonas Busch, Begona Perez-Valderrama, Guillermo de Velasco, Ignacio Duran, Marc Schmitz, Rebekka Wehner

JOURNAL OF CLINICAL ONCOLOGY (2022)

Add to Collection

Article Medicine, General & Internal

Internet-based cognitive-behavioural writing therapy for reducing post-traumatic stress after severe sepsis in patients and their spouses (REPAIR): results of a randomised-controlled trial

Romina Gawlytta, Miriam Kesselmeier, Andre Scherag, Helen Niemeyer, Maria Boettche, Christine Knaevelsrud, Jenny Rosendahl

Summary: This study aimed to investigate the efficacy, safety, and applicability of internet-based, therapist-led partner-assisted cognitive-behavioural writing therapy (iCBT) for post-traumatic stress disorder (PTSD) symptoms after sepsis in patients and their spouses. The results showed that iCBT was applicable and safe but did not provide evidence for its efficacy in reducing PTSD symptom severity.

BMJ OPEN (2022)

Add to Collection

Article Public, Environmental & Occupational Health

POLAR-POLypharmacy, drug interActions and Risks-how can data from inpatient care support their assessment?

Andre Scherag, Wahram Andrikyan, Tobias Dreischulte, Pauline Duerr, Martin F. Fromm, Jan Gewehr, Ulrich Jaehde, Miriam Kesselmeier, Renke Maas, Petra A. Thuermann, Frank Meineke, Daniel Neumann, Julia Palm, Thomas Peschel, Editha Raeuscher, Susann Schulze, Torsten Thalheim, Thomas Wendt, Markus Loeffler

Summary: This article presents the POLAR project, which aims to detect medication risks in patients with polymedication using real world data. By utilizing distributed analyses and international information technology standards, it is demonstrated for the first time that inpatient treatment data can be exchanged and utilized in a privacy-compliant manner.

PRAVENTION UND GESUNDHEITSFORDERUNG (2022)

Add to Collection

Article Infectious Diseases

Non-patient-related SARS-CoV-2 exposure from colleagues and household members poses the highest infection risk for hospital employees in a German university hospital: follow-up of the prospective Co-HCW seroprevalence study

Christina Bahrs, Sebastian Weis, Miriam Kesselmeier, Juliane Ankert, Stefan Hagel, Stephanie Beier, Jens Maschmann, Andreas Stallmach, Andrea Steiner, Michael Bauer, Wilhelm Behringer, Michael Baier, Cora Richert, Florian Zepf, Martin Walter, Andre Scherag, Michael Kiehntopf, Bettina Loeffler, Mathias W. Pletz

Summary: This study aims to assess the SARS-CoV-2 seroprevalence and infection status in staff members of Jena University Hospital in Germany. The results show that non-patient-related exposure to SARS-CoV-2 posed the highest infection risk for hospital staff members, with contact with household members and colleagues significantly increasing the risk of infection.

INFECTION (2023)

Add to Collection

Letter Infectious Diseases

Introduction of mandatory masking in health care and community: experience from Jena, Germany

Mathias W. W. Pletz, Andrea Steiner, Miriam Kesselmeier, Bettina Loeffler, Jens Maschmann, Andreas Stallmach, Sabine Trommer

INFECTION (2023)

Add to Collection

Article Medicine, General & Internal

Planning adaptive treatment by longitudinal response assessment implementing MR imaging, liquid biopsy and analysis of microenvironment during neoadjuvant treatment of rectal cancer (PRIMO)

Georg W. Wurschi, Daniel Guellmar, Nikolaus Gassler, Joachim Clement, Miriam Kesselmeier, Julia J. Mueller-Wurschi, Utz Settmacher, Henning Mothes, Herry Helfritzsch, Yves Liebe, Tobias Franiel, Matthias A. Maeurer, Thomas Ernst, Nils H. Nicolay, Andrea Wittig

Summary: This study aims to evaluate early treatment response and establish a noninvasive response prediction model for personalized treatment adaptations based on response.

MEDICINE (2023)

Add to Collection

Article Health Care Sciences & Services

Psychometric properties of the Reintegration to Normal Living Index for sepsis survivors

Kathleen Streich, Christiane S. Hartog, Carolin Fleischmann-Struzek, Norman Rose, Anna Bichmann, Miriam Kesselmeier, Fridtjof Schiefenhoevel, Malte Schmieding, Sebastian Born

Summary: This study analyzed the psychometric properties of the German version of the Reintegration to Normal Living Index (RNLI) in sepsis survivors. The results showed good reliability, structural and concurrent validity of the RNLI in German sepsis survivors. The authors suggest using the RNLI in addition to generic health-related quality of life measures to assess reintegration to normal living after sepsis.

QUALITY OF LIFE RESEARCH (2023)

Add to Collection

Article Psychiatry

Differential Effects of an Internet-Based Cognitive-Behavioral Writing Therapy for Reducing PTSD Symptoms after Intensive Care: Results of a Per-Protocol Analysis

Johannes Reck, Romina Gawlytta, Miriam Kesselmeier, Maria Boettche, Helen Niemeyer, Christine Knaevelsrud, Jenny Rosendahl

Summary: This study aimed to investigate the differential effects of internet-based cognitive-behavioral writing therapy (iCBT) on post-traumatic stress disorder (PTSD) symptoms in patients and their spouses after intensive care. A reanalysis of a randomized controlled trial found a significant reduction in post-traumatic symptom severity after iCBT. The number of words written by participants in therapy modules had a significant impact on the efficacy of iCBT.

PSYCHIATRISCHE PRAXIS (2023)

Add to Collection

Article Gastroenterology & Hepatology

Immunomodulator comedication promotes the reversal of anti-drug antibody-mediated loss of response to anti-TNF therapy in inflammatory bowel disease

Johannes Stallhofer, Jan Guse, Miriam Kesselmeier, Philip Christian Grunert, Kathleen Lange, Robert Stalmann, Verena Eckardt, Andreas Stallmach

Summary: This study aimed to investigate the effects of immunomodulator comedication on anti-drug antibodies in patients with inflammatory bowel disease. The results of a real-world retrospective cohort study showed that immunomodulator comedication can successfully reverse the loss of therapeutic response to tumor necrosis factor inhibitors.

INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2023)

Add to Collection

Meeting Abstract Pediatrics

Longitudinal Clinical and Pulmonary Characteristics of Children with Post-COVID-19 Conditions

B. Woerner, M. Rasche, M. Pavlova, M. Kesselmeier, M. Lorenz

PEDIATRIC PULMONOLOGY (2022)

Add to Collection

Meeting Abstract Respiratory System

Validation of the qSOFA(-65) score compared to the CRB-65 score for risk prediction in community-acquired pneumonia

M. Kesselmeier, M. Pletz, A. Scherag, T. Bauer, S. Ewig, M. Kolditz

PNEUMOLOGIE (2022)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.